Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	May 31, 2016	May 31, 2015
Operating activities:
Net loss	$ (745,290)	$ (501,391)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation		4,000
Loss on abandonment of assets	(81,466)
Amortization of debt discount	369,576	305,153
Amortization of financing costs		5,305
Gain on troubled debt restructuring		(2,065,614)
Impairment of investment	180,000
Gain on settlement of derivative liabilities		(1,223,448)
Change in fair value of derivative liabilities	(603,576)	3,017,461
Changes in operating assets and liabilities:
Accounts receivable	7,183
Inventory	40,001
Customer deposits		65,000
Prepaid expenses and other current assets	101	3,337
Other assets		(31,337)
Accounts payable and accrued liabilities	141,672	205,417
Accounts payable and accrued liabilities - related party	237,510	148,457
Due to Pension Benefit Guaranty Corporation	53,013	50,434
Net cash used in operating activities	(238,344)	(82,226)
Cash flows from investing activities:
Cash acquired in Canalytix acquisition		303
Decrease in cash placed under restriction	7,499
Net cash provided by investing activities	7,499	303
Cash flows from financing activities:
Proceeds from borrowings	26,810	130,500
Proceeds from related party borrowings	206,039
Principal payments of debt	(9,472)	(44,100)
Net cash provided by financing activities	223,377	86,400
Increase (decrease) in cash and cash equivalents	(7,468)	4,477
Cash and cash equivalents at beginning of period	8,978	1,832
Cash and cash equivalents at the end of period	1,510	6,309
Supplemental disclosure of cash flow information:
Cash paid during the period for:Income taxes
Cash paid during the period for:Interest	27,828
Non-cash financing transactions:
Fair value of derivative liabilities to discount on debt	571,223	193,780
Settlement of payables with common stock	25,000
Settlement of accrued interest with issuance of preferred stock		100,000
Settlement of payables with issuance of warrants		20,000
Conversion of accrued liabilities to notes payable		150,731
Excess of purchase price over value of assets		$ 410,839